1 | Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer. 2018;37:4903 doi: 10.1038/s41388-018-0341-x |
2 | Malignant Bowel Obstruction due to Metastatic Carcinoma of Buccal Mucosa - A Case Report. 2021;8:1998 doi: 10.18410/jebmh/2021/375 |
3 | Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases. 2020;18:229 doi: 10.1158/1541-7786.MCR-19-0688 |
4 | Molecular Profiles and Metastasis Markers in Chinese Patients with Gastric Carcinoma. 2019;9: doi: 10.1038/s41598-019-50171-7 |
5 | THE EFFECT OF CYTOREDUCTIVE SURGERY AND INTRAPERITONEAL HYPERTHERMIC CHEMOPERFUSION (HIPEC) ON THE CLINICAL OUTCOME OF TREATMENT OF PATIENTS WITH ADVANCED GASTRIC CANCER. 2021; doi: 10.54229/2226-2008-2021-5-5 |
6 | Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach. 2020;21:951 doi: 10.3390/ijms21030951 |
7 | Ligaments and Lymphatic Pathways in Gastric Adenocarcinoma. 2019;39:668 doi: 10.1148/rg.2019180113 |
8 | The role of surgery in advanced disease for esophageal and junctional cancer. 2018;36-37:91 doi: 10.1016/j.bpg.2018.11.002 |
9 | Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview. 2019;36:1 doi: 10.1007/s10585-019-09955-4 |
10 | Pathology of Peritoneal Metastases. 2020;251 doi: 10.1007/978-981-15-3773-8_12 |